Laura Chico, Ph.D.

Managing Director, Equity Research

(213) 688-8000
141 W. Jackson Boulevard
1710-A
Chicago, IL 60604

AREA OF FOCUS

Biotechnology

ANALYST BIOGRAPHY

Laura Chico, Ph.D brings more than a decade of experience in the biotechnology and drug discovery industry, as well as more than a decade in Equity Research. During her career, Laura has served as Vice President Equity Research at Raymond James, and as a biotech analyst in the Robert W. Baird Equity Research Healthcare group. Before entering equity research, Laura held scientific roles in both industry and academic settings with focus in central nervous system (“CNS”) diseases such as Alzheimer’s disease.

Laura received her B.S. in Bacteriology from the University of Wisconsin-Madison, her M.S. in Computational Biology & Bioinformatics, and her Ph.D. in Molecular Pharmacology, from Northwestern University.

ANALYST EDGE

Laura’s Edge: Her combination of scientific, research, and academic communities experiences, gives Laura a deeper understanding and ability to translate complex data sets for investors.

COMPANIES UNDER COVERAGE

  • Alto Neuroscience, Inc. (ANRO)
  • Ardelyx (ARDX)
  • BioCryst Pharmaceuticals (BCRX)
  • Biogen, Inc. (BIIB)
  • Climb Bio (CLYM)
  • Denali Therapeutics (DNLI)
  • Dianthus Therapeutics, Inc. (DNTH)
  • Edgewise Therapeutics Inc (EWTX)
  • Gossamer Bio (GOSS)
  • Jade Biosciences, Inc. (JBIO)
  • Larimar Therapeutics, Inc. (LRMR)
  • Maze Therapeutics, Inc. (MAZE)
  • Neurocrine Biosciences, Inc. (NBIX)
  • Ovid Therapeutics, Inc. (OVID)
  • PepGen Inc. (PEPG)
  • Pharvaris N. V. (PHVS)
  • Praxis Precision Medicines, Inc. (PRAX)
  • Sionna Therapeutics (SION)
  • Solid Biosciences Inc. (SLDB)
  • Stoke Therapeutics (STOK)
  • Travere Therapeutics (TVTX)
  • Ultragenyx Pharmaceutical Inc (RARE)
  • Vera Therapeutics, Inc. (VERA)
  • Viridian Therapeutics, Inc. (VRDN)
  • Xenon Pharmaceuticals (XENE)